‘Brain Cancer’ Neuroscience Articles
What Causes Brain Cancer? Understanding Glioblastoma
Understanding glioblastoma at the genetic, molecular level Glioblastoma is the most common and most lethal form of brain tumor in people. Research published in the International Journal of Computational Biology and Drug Design offers a novel way to determine what biological [Read More]
63rd Annual Meeting of the American Academy of Neurology – 2011
The American Academy of Neurology is holding their 63rd annual meeting from April 9 - 16, 2011 in Honolulu, Hawaii, USA. [Read More]
FLIP Switch of Programmed Cell Death
Research involving programmed cell death has lead to new information about the involvement of a protein named FLIP in cell survival and cell death. Researchers identified the protein FLIP and the silencing of the enzyme RIPK3 as important clues to the confusing nature of [Read More]
Genetic Mutations in Brain Tumors Could Turn Out Useful
Scientists have discovered genetic mutations in brain tumors that alter brain tumor metabolism. The scientists report that cells with defective IDH1 or IDH2 genes had over 100 more metabolites with altered concentrations than cells without defective IDH1 or IDH2 genes. One [Read More]
Zif Protein Controls Brain Stem Cells
Zif proteins have been found to control whether a brain stem cell differentiates into a neuron or renews as a brain stem cell. There are Zif related proteins in humans that may be targeted by new treatments for brain cancer and other diseases. [Read More]
Breast Cancer Patients’ Brain Tissue Altered by Chemotherapy
Brain imaging studies of women with breast cancer before and after chemotherapy treatments show grey matter is being affected during the chemotherapy treatments. Brain areas believed to be critical for multi-tasking, memory and other cognitive functions were seen to change [Read More]
Neuroscience Research Uncovers New Role of IDH1 Gene Mutation in Brain Cancer
Findings Validate Cancer Metabolism as an Approach to Identify New Ways to Treat Cancer - Opens Potential for New Class of Cancer Drugs Targeting Metabolic Enzymes Cambridge, MA Agios Pharmaceuticals today announced that its scientists have established, for the first time, [Read More]
